LONDON, UK — Both CV-event rates and prevalence of serious gastrointestinal complications were surprisingly low in people without heart disease taking either celecoxib (Celebrex, Pfizer) or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results